JP Morgan analyst Jeremy Tonet upgrades MPLX (NYSE:MPLX) from Neutral to Overweight and raises the price target from $37 to $41.
Why Beneficient (BENF) Shares Are Exploding Higher
Beneficient shares are trading higher by 290% during Friday's session. The company announced it regained compliance with the Nasdaq.